Tapewire

Nasdaq · USD

FLGT

Fulgent Genetics, Inc.

Export transactions ↓
Tapewire entity
2545
SEC CIK
0001674930
Parsed reports
401

Last 12 months

Inside the activity.

0 purchase rows · 15 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202505
Dec 202502
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202602
Jun 202602
Jul 202600
Aug 202602
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 24, 2026 Filed Feb 26, 2026 01:17 UTC
Gao HanlinChief Scientific Officer
GrantCommon Stock 22,806 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-072639 · ownership.xml · nonDerivative · entry 4

Gao Hanlin · CIK 0001684532 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 991,615

F4 · shares: Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 25, 2025.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 01:17 UTC
Gao HanlinChief Scientific Officer
GrantCommon Stock 12,762 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-072639 · ownership.xml · nonDerivative · entry 3

Gao Hanlin · CIK 0001684532 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 968,809

F3 · shares: Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 26, 2024.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 01:17 UTC
Gao HanlinChief Scientific Officer
GrantCommon Stock 4,891 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-072639 · ownership.xml · nonDerivative · entry 2

Gao Hanlin · CIK 0001684532 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 956,047

F2 · shares: Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 23, 2023.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 01:18 UTC
Kim PaulCFO and Treasurer
GrantCommon Stock 31,182 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-072641 · ownership.xml · nonDerivative · entry 8

Kim Paul · CIK 0001253820 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 379,195

F8 · shares: Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after March 1, 2026, and 1/12th of such shares vesting at the end of every three-month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 01:18 UTC
Kim PaulCFO and Treasurer
Tax withholdingCommon Stock 15,095 $23.09 $348,543.55
Disclosure

SEC source: 0001193125-26-072641 · ownership.xml · nonDerivative · entry 7

Kim Paul · CIK 0001253820 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 348,013

F7 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 25, 2025.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 01:18 UTC
Kim PaulCFO and Treasurer
Tax withholdingCommon Stock 8,456 $23.09 $195,249.04
Disclosure

SEC source: 0001193125-26-072641 · ownership.xml · nonDerivative · entry 6

Kim Paul · CIK 0001253820 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 363,108

F6 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 26, 2024.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 01:18 UTC
Kim PaulCFO and Treasurer
Tax withholdingCommon Stock 3,241 $23.09 $74,834.69
Disclosure

SEC source: 0001193125-26-072641 · ownership.xml · nonDerivative · entry 5

Kim Paul · CIK 0001253820 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 371,564

F5 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 23, 2023.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 01:18 UTC
Kim PaulCFO and Treasurer
GrantCommon Stock 26,673 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-072641 · ownership.xml · nonDerivative · entry 4

Kim Paul · CIK 0001253820 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 374,805

F4 · shares: Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 25, 2025.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 01:18 UTC
Kim PaulCFO and Treasurer
GrantCommon Stock 14,926 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-072641 · ownership.xml · nonDerivative · entry 3

Kim Paul · CIK 0001253820 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 348,132

F3 · shares: Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 26, 2024.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 01:18 UTC
Kim PaulCFO and Treasurer
GrantCommon Stock 5,721 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-072641 · ownership.xml · nonDerivative · entry 2

Kim Paul · CIK 0001253820 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 333,206

F2 · shares: Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 23, 2023.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 01:17 UTC
Hsieh MingDirector · Chief Executive Officer · 10% owner
GrantCommon Stock 69,294 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-072637 · ownership.xml · nonDerivative · entry 8

Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 921,149

F8 · shares: Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after March 1, 2026, and 1/12th of such shares vesting at the end of every three-month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 01:17 UTC
Hsieh MingDirector · Chief Executive Officer · 10% owner
Tax withholdingCommon Stock 31,760 $23.09 $733,338.40
Disclosure

SEC source: 0001193125-26-072637 · ownership.xml · nonDerivative · entry 7

Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 851,855

F7 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 25, 2025.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 01:17 UTC
Hsieh MingDirector · Chief Executive Officer · 10% owner
Tax withholdingCommon Stock 21,354 $23.09 $493,063.86
Disclosure

SEC source: 0001193125-26-072637 · ownership.xml · nonDerivative · entry 6

Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 883,615

F6 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 26, 2024.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 01:17 UTC
Hsieh MingDirector · Chief Executive Officer · 10% owner
Tax withholdingCommon Stock 10,230 $23.09 $236,210.70
Disclosure

SEC source: 0001193125-26-072637 · ownership.xml · nonDerivative · entry 5

Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 904,969

F5 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 23, 2023.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 01:17 UTC
Hsieh MingDirector · Chief Executive Officer · 10% owner
GrantCommon Stock 59,276 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-072637 · ownership.xml · nonDerivative · entry 4

Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 915,199

F4 · shares: Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 25, 2025.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 01:17 UTC
Hsieh MingDirector · Chief Executive Officer · 10% owner
GrantCommon Stock 39,802 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-072637 · ownership.xml · nonDerivative · entry 3

Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 855,923

F3 · shares: Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 26, 2024.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 01:17 UTC
Hsieh MingDirector · Chief Executive Officer · 10% owner
GrantCommon Stock 19,067 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-072637 · ownership.xml · nonDerivative · entry 2

Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 816,121

F2 · shares: Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 23, 2023.

Read SEC document
February 23, 2026 Filed Feb 26, 2026 01:18 UTC
Xie JianPresident and COO
Tax withholdingCommon Stock 655 $23.01 $15,071.55
Disclosure

SEC source: 0001193125-26-072640 · ownership.xml · nonDerivative · entry 1

Xie Jian · CIK 0001819718 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 331,383

F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023.

Read SEC document
February 23, 2026 Filed Feb 26, 2026 01:17 UTC
Gao HanlinChief Scientific Officer
Tax withholdingCommon Stock 403 $23.01 $9,273.03
Disclosure

SEC source: 0001193125-26-072639 · ownership.xml · nonDerivative · entry 1

Gao Hanlin · CIK 0001684532 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 951,156

F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023.

Read SEC document
February 23, 2026 Filed Feb 26, 2026 01:18 UTC
Kim PaulCFO and Treasurer
Tax withholdingCommon Stock 661 $23.01 $15,209.61
Disclosure

SEC source: 0001193125-26-072641 · ownership.xml · nonDerivative · entry 1

Kim Paul · CIK 0001253820 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 327,485

F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023.

Read SEC document
February 23, 2026 Filed Feb 26, 2026 01:17 UTC
Hsieh MingDirector · Chief Executive Officer · 10% owner
Tax withholdingCommon Stock 2,167 $23.01 $49,862.67
Disclosure

SEC source: 0001193125-26-072637 · ownership.xml · nonDerivative · entry 1

Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 797,054

F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023.

Read SEC document
January 26, 2026 Filed Jan 28, 2026 22:02 UTC
Xie JianPresident and COO
Tax withholdingCommon Stock 4,711 $27.53 $129,693.83
Disclosure

SEC source: 0001193125-26-027402 · ownership.xml · nonDerivative · entry 1

Xie Jian · CIK 0001819718 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 332,038

F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022.

Read SEC document
January 26, 2026 Filed Jan 28, 2026 22:02 UTC
Gao HanlinChief Scientific Officer
Tax withholdingCommon Stock 1,331 $27.53 $36,642.43
Disclosure

SEC source: 0001193125-26-027405 · ownership.xml · nonDerivative · entry 1

Gao Hanlin · CIK 0001684532 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 951,559

F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022.

Read SEC document
January 26, 2026 Filed Jan 28, 2026 22:01 UTC
Kim PaulCFO and Treasurer
Tax withholdingCommon Stock 3,004 $27.53 $82,700.12
Disclosure

SEC source: 0001193125-26-027397 · ownership.xml · nonDerivative · entry 1

Kim Paul · CIK 0001253820 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 328,146

F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022.

Read SEC document
December 02, 2025 Filed Dec 3, 2025 22:04 UTC
Xie JianPresident and COO
SaleCommon Stock 1,140 $28.33 $32,298.25
Disclosure

SEC source: 0001193125-25-306921 · ownership.xml · nonDerivative · entry 1

Xie Jian · CIK 0001819718 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 336,749

F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022.

F2 · price: The shares were sold in multiple transactions at prices ranging from $28.27 to $28.38, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
December 02, 2025 Filed Dec 3, 2025 22:04 UTC
Gao HanlinChief Scientific Officer
SaleCommon Stock 1,075 $28.33 $30,456.69
Disclosure

SEC source: 0001193125-25-306920 · ownership.xml · nonDerivative · entry 1

Gao Hanlin · CIK 0001684532 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 952,890

F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022.

F2 · price: The shares were sold in multiple transactions at prices ranging from $28.27 to $28.38, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
December 01, 2025 Filed Dec 3, 2025 22:04 UTC
Kim PaulCFO and Treasurer
Tax withholdingCommon Stock 1,131 $28.52 $32,256.12
Disclosure

SEC source: 0001193125-25-306924 · ownership.xml · nonDerivative · entry 1

Kim Paul · CIK 0001253820 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 331,150

F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022.

Read SEC document
November 28, 2025 Filed Dec 2, 2025 02:14 UTC
Xie JianPresident and COO
SaleCommon Stock 1,198 $29.57 $35,424.26
Disclosure

SEC source: 0001193125-25-304294 · ownership.xml · nonDerivative · entry 1

Xie Jian · CIK 0001819718 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 337,889

F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024.

F2 · price: The shares were sold in multiple transactions at prices ranging from $29.45 to $29.67, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
November 28, 2025 Filed Dec 2, 2025 02:14 UTC
Gao HanlinChief Scientific Officer
SaleCommon Stock 943 $29.57 $27,884.04
Disclosure

SEC source: 0001193125-25-304293 · ownership.xml · nonDerivative · entry 1

Gao Hanlin · CIK 0001684532 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 953,965

F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024.

F2 · price: The shares were sold in multiple transactions at prices ranging from $29.45 to $29.67, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
November 26, 2025 Filed Dec 2, 2025 00:00 UTC
Kim PaulCFO and Treasurer
Tax withholdingCommon Stock 1,166 $30.15 $35,154.90
Disclosure

SEC source: 0001193125-25-304201 · ownership.xml · nonDerivative · entry 1

Kim Paul · CIK 0001253820 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 332,281

F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024.

Read SEC document
November 26, 2025 Filed Dec 2, 2025 00:00 UTC
Hsieh MingDirector · Chief Executive Officer · 10% owner
Tax withholdingCommon Stock 2,944 $30.15 $88,761.60
Disclosure

SEC source: 0001193125-25-304200 · ownership.xml · nonDerivative · entry 1

Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 799,221

F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024.

Read SEC document
November 24, 2025 Filed Nov 25, 2025 21:30 UTC
Xie JianPresident and COO
SaleCommon Stock 681 $30.47 $20,752.11
Disclosure

SEC source: 0001193125-25-297323 · ownership.xml · nonDerivative · entry 1

Xie Jian · CIK 0001819718 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 339,087

F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023.

F2 · price: The shares were sold in multiple transactions at prices ranging from $30.33 to $30.62, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
November 24, 2025 Filed Nov 25, 2025 21:30 UTC
Gao HanlinChief Scientific Officer
SaleCommon Stock 535 $30.47 $16,303.06
Disclosure

SEC source: 0001193125-25-297321 · ownership.xml · nonDerivative · entry 1

Gao Hanlin · CIK 0001684532 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 954,908

F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023.

F2 · price: The shares were sold in multiple transactions at prices ranging from $30.33 to $30.62, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
November 23, 2025 Filed Nov 25, 2025 21:30 UTC
Hsieh MingDirector · Chief Executive Officer · 10% owner
Tax withholdingCommon Stock 2,116 $30.00 $63,480.00
Disclosure

SEC source: 0001193125-25-297327 · ownership.xml · nonDerivative · entry 1

Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 802,165

F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023.

Read SEC document
November 23, 2025 Filed Nov 25, 2025 21:30 UTC
Kim PaulCFO and Treasurer
Tax withholdingCommon Stock 671 $30.00 $20,130.00
Disclosure

SEC source: 0001193125-25-297326 · ownership.xml · nonDerivative · entry 1

Kim Paul · CIK 0001253820 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 333,447

F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023.

Read SEC document
November 19, 2025 Filed Nov 21, 2025 21:30 UTC
Xie JianPresident and COO
GiftCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-291451 · ownership.xml · nonDerivative · entry 2

Xie Jian · CIK 0001819718 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 339,768

F3 · shares: Reflects shares transferred as a gift to the James and Karena Xie Family Foundation (the "Foundation"), of which, the reporting person is the president and has voting and investment power over all securities owned by the foundation.

Read SEC document
November 19, 2025 Filed Nov 21, 2025 21:30 UTC
Xie JianPresident and COO
SaleCommon Stock 10,000 $29.10 $290,983.00
Disclosure

SEC source: 0001193125-25-291451 · ownership.xml · nonDerivative · entry 1

Xie Jian · CIK 0001819718 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 349,768

F1 · shares: The shares were sold by the reporting person for year-end tax planning.

F2 · price: The shares were sold in multiple transactions at prices ranging from $29.07 to $29.1985, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
October 26, 2025 Filed Oct 28, 2025 21:20 UTC
Xie JianPresident and COO
Tax withholdingCommon Stock 4,353 $23.74 $103,340.22
Disclosure

SEC source: 0001193125-25-253871 · ownership.xml · nonDerivative · entry 1

Xie Jian · CIK 0001819718 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 359,768

F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022.

Read SEC document
October 26, 2025 Filed Oct 28, 2025 21:20 UTC
Gao HanlinChief Scientific Officer
Tax withholdingCommon Stock 1,642 $23.74 $38,981.08
Disclosure

SEC source: 0001193125-25-253873 · ownership.xml · nonDerivative · entry 1

Gao Hanlin · CIK 0001684532 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 955,443

F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022.

Read SEC document
October 26, 2025 Filed Oct 28, 2025 21:20 UTC
Kim PaulCFO and Treasurer
Tax withholdingCommon Stock 2,743 $23.74 $65,118.82
Disclosure

SEC source: 0001193125-25-253872 · ownership.xml · nonDerivative · entry 1

Kim Paul · CIK 0001253820 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 334,118

F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022.

Read SEC document
September 03, 2025 Filed Sep 3, 2025 21:33 UTC
Xie JianPresident and COO
SaleCommon Stock 1,128 $22.03 $24,846.12
Disclosure

SEC source: 0001819718-25-000022 · ownership.xml · nonDerivative · entry 1

Xie Jian · CIK 0001819718 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 364,121

F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022.

F2 · price: The shares were sold in multiple transactions at prices ranging from $21.92 to $22.175, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
September 03, 2025 Filed Sep 3, 2025 21:33 UTC
Gao HanlinChief Scientific Officer
SaleCommon Stock 1,063 $22.03 $23,414.38
Disclosure

SEC source: 0001684532-25-000014 · ownership.xml · nonDerivative · entry 1

Gao Hanlin · CIK 0001684532 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 957,085

F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022.

F2 · price: The shares were sold in multiple transactions at prices ranging from $21.92 to $22.175, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
September 01, 2025 Filed Sep 3, 2025 21:31 UTC
Kim PaulCFO and Treasurer
Tax withholdingCommon Stock 1,131 $22.17 $25,074.27
Disclosure

SEC source: 0001253820-25-000008 · ownership.xml · nonDerivative · entry 1

Kim Paul · CIK 0001253820 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 336,861

F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022.

Read SEC document
August 27, 2025 Filed Aug 28, 2025 22:55 UTC
Xie JianPresident and COO
SaleCommon Stock 1,199 $21.48 $25,760.16
Disclosure

SEC source: 0001819718-25-000018 · ownership.xml · nonDerivative · entry 1

Xie Jian · CIK 0001819718 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 365,249

F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024.

F2 · price: The shares were sold in multiple transactions at prices ranging from $21.28 to $21.66, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
August 27, 2025 Filed Aug 28, 2025 22:55 UTC
Gao HanlinChief Scientific Officer
SaleCommon Stock 943 $21.48 $20,260.07
Disclosure

SEC source: 0001684532-25-000010 · ownership.xml · nonDerivative · entry 1

Gao Hanlin · CIK 0001684532 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 958,148

F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024.

F2 · price: The shares were sold in multiple transactions at prices ranging from $21.28 to $21.66, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
August 26, 2025 Filed Aug 28, 2025 22:55 UTC
Hsieh MingDirector · Chief Executive Officer · 10% owner
Tax withholdingCommon Stock 2,944 $21.47 $63,207.68
Disclosure

SEC source: 0001302110-25-000006 · ownership.xml · nonDerivative · entry 1

Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 804,281

F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024.

Read SEC document
August 26, 2025 Filed Aug 28, 2025 22:55 UTC
Kim PaulCFO and Treasurer
Tax withholdingCommon Stock 1,166 $21.47 $25,034.02
Disclosure

SEC source: 0001253820-25-000006 · ownership.xml · nonDerivative · entry 1

Kim Paul · CIK 0001253820 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 337,992

F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024.

Read SEC document
August 25, 2025 Filed Aug 26, 2025 23:13 UTC
Xie JianPresident and COO
SaleCommon Stock 696 $21.50 $14,965.11
Disclosure

SEC source: 0001819718-25-000008 · ownership.xml · nonDerivative · entry 1

Xie Jian · CIK 0001819718 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 366,448

F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023.

F2 · price: The shares were sold in multiple transactions at prices ranging from $21.46 to $21.57, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
August 25, 2025 Filed Aug 26, 2025 23:10 UTC
Gao HanlinChief Scientific Officer
SaleCommon Stock 548 $21.50 $11,782.88
Disclosure

SEC source: 0001684532-25-000005 · ownership.xml · nonDerivative · entry 1

Gao Hanlin · CIK 0001684532 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 959,091

F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023.

F2 · price: The shares were sold in multiple transactions at prices ranging from $21.46 to $21.57, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
August 23, 2025 Filed Aug 26, 2025 23:12 UTC
Hsieh MingDirector · Chief Executive Officer · 10% owner
Tax withholdingCommon Stock 2,115 $21.77 $46,043.55
Disclosure

SEC source: 0001302110-25-000004 · ownership.xml · nonDerivative · entry 1

Hsieh Ming · CIK 0001302110 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 807,225

F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.